Capsular Polysaccharide A Ameliorates Ulcerative Colitis in Rat by Recovering Intestinal Barrier Integrity and Restoring Gut Microbiota

Overview

Journal Front Pharmacol

Date 2025 Jan 8

PMID 39776580

Authors

Yijia Zhong

Xiujuan Chang

Zihan Zhao

Lijun Zheng

Gaobo Kuang

Ping Li

Chenxuexuan Liu

Yuqin Fan

Zhixuan Liang

Ke Zhuang

Qiuling Xie

YangYang Liu

Affiliations

Soon will be listed here.

Abstract

() is a Gram-negative, obligate anaerobic, commensal bacterium residing in the human gut and holds therapeutic potential for ulcerative colitis (UC). Previous studies have indicated that capsular polysaccharide A (PSA) of is a crucial component for its effectiveness, possessing various biological activities such as anti-inflammatory, anti-tumor, and immune-modulating effects. We previously isolated and characterized the strain ZY-312 from the feces of a healthy breastfed infant, and extracted its PSA, named TP2. In this study, we explored the impact of TP2 on colonic inflammation and delved into its potential mechanisms. Initially, we used 2,4,6-trinitrobenzenesulfonic acid (TNBS) to induce colitis in rats and found that TP2 treatment significantly ameliorated TNBS-induced weight loss, increased clinical scores, extensive ulcers, and intestinal epithelial damage in UC rats. Further analysis revealed that TP2 effectively restored the intestinal barrier integrity in UC rats by regulating the expression of Muc-2, tight junction proteins (ZO-1, occludin, claudin-1, and claudin-2), as well as apoptosis-related proteins Bcl-2, BAX, and Cleaved-Caspase-3. Additionally, TP2 suppressed the expression of pro-inflammatory cytokines TNF-α, IL-1β, IL-6, and IL23, while promoting the secretion of anti-inflammatory cytokines IL-10 and IL-22, thereby inhibiting the occurrence of inflammation. TP2 also downregulated the phosphorylation levels of AKT and PI3K, effectively inhibiting the abnormal activation of the PI3K/AKT signaling pathway. More interestingly, 16S rRNA sequencing results showed that TP2 restored the ecological imbalance of the rat intestinal microbiota, with an increase in beneficial bacteria such as and observed in the treatment group. In conclusion, TP2 through the regulation of intestinal barrier-related cells and proteins, inhibition of apoptosis, modulation of inflammation-related cytokine levels, and control of abnormal activation of the PI3K/AKT signaling pathway, restores intestinal barrier integrity. Additionally, by reshaping the ecological imbalance of the gut microbiota, TP2 ultimately alleviates ulcerative colitis in rats.

References

Motavallian-Naeini A, Andalib S, Rabbani M, Mahzouni P, Afsharipour M, Minaiyan M . Validation and optimization of experimental colitis induction in rats using 2, 4, 6-trinitrobenzene sulfonic acid. Res Pharm Sci. 2012; 7(3):159-69. PMC: 3501925. View

Deng H, Yang S, Zhang Y, Qian K, Zhang Z, Liu Y . Corrigendum: Prevents Infection in a Mouse Model by Restoring Gut Barrier and Microbiome Regulation. Front Microbiol. 2019; 10:601. PMC: 6454232. DOI: 10.3389/fmicb.2019.00601. View

Li Z, Zhang S, Xu L, Fang X, Wan Y, Yu D . A tetrapeptide from maize combined with probiotics exerted strong anti-inflammatory effects and modulated gut microbiota in DSS-induced colitis mice. Food Funct. 2022; 13(24):12602-12618. DOI: 10.1039/d2fo02678c. View

Bilsborough J, Fiorino M, Henkle B . Select animal models of colitis and their value in predicting clinical efficacy of biological therapies in ulcerative colitis. Expert Opin Drug Discov. 2020; 16(5):567-577. DOI: 10.1080/17460441.2021.1851185. View

McGuckin M, Eri R, Simms L, Florin T, Radford-Smith G . Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm Bowel Dis. 2008; 15(1):100-13. DOI: 10.1002/ibd.20539. View

Zhou M, Zhi J, Zhi J, Xiong Z, Wu F, Lu Y . Polysaccharide from Strongylocentrotus nudus eggs regulates intestinal epithelial autophagy through CD36/PI3K-Akt pathway to ameliorate inflammatory bowel disease. Int J Biol Macromol. 2023; 244:125373. DOI: 10.1016/j.ijbiomac.2023.125373. View

Hansson G . Role of mucus layers in gut infection and inflammation. Curr Opin Microbiol. 2011; 15(1):57-62. PMC: 3716454. DOI: 10.1016/j.mib.2011.11.002. View

Vetizou M, Pitt J, Daillere R, Lepage P, Waldschmitt N, Flament C . Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science. 2015; 350(6264):1079-84. PMC: 4721659. DOI: 10.1126/science.aad1329. View

Zheng L, Luo M, Kuang G, Liu Y, Liang D, Huang H . Capsular Polysaccharide From Protects Against Ulcerative Colitis in an Undegraded Form. Front Pharmacol. 2020; 11:570476. PMC: 7751226. DOI: 10.3389/fphar.2020.570476. View

10.

Tokuhira N, Kitagishi Y, Suzuki M, Minami A, Nakanishi A, Ono Y . PI3K/AKT/PTEN pathway as a target for Crohn's disease therapy (Review). Int J Mol Med. 2014; 35(1):10-6. DOI: 10.3892/ijmm.2014.1981. View

11.

Lane E, Zisman T, Suskind D . The microbiota in inflammatory bowel disease: current and therapeutic insights. J Inflamm Res. 2017; 10:63-73. PMC: 5473501. DOI: 10.2147/JIR.S116088. View

12.

Gunzel D, Fromm M . Claudins and other tight junction proteins. Compr Physiol. 2013; 2(3):1819-52. DOI: 10.1002/cphy.c110045. View

13.

Kotla N, Mohd Isa I, Rasala S, Demir S, Singh R, Baby B . Modulation of Gut Barrier Functions in Ulcerative Colitis by Hyaluronic Acid System. Adv Sci (Weinh). 2021; 9(4):e2103189. PMC: 8811821. DOI: 10.1002/advs.202103189. View

14.

Riedl S, Shi Y . Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 2004; 5(11):897-907. DOI: 10.1038/nrm1496. View

15.

Nunes-Santos C, Uzel G, Rosenzweig S . PI3K pathway defects leading to immunodeficiency and immune dysregulation. J Allergy Clin Immunol. 2019; 143(5):1676-1687. DOI: 10.1016/j.jaci.2019.03.017. View

16.

Johnson J, Jones M, Cobb B . Polysaccharide-experienced effector T cells induce IL-10 in FoxP3+ regulatory T cells to prevent pulmonary inflammation. Glycobiology. 2017; 28(1):50-58. PMC: 5972631. DOI: 10.1093/glycob/cwx093. View

17.

He X, Liu D, Liu H, Wu D, Li H, Zhang X . Prevention of Ulcerative Colitis in Mice by Sweet Tea () via the Regulation of Gut Microbiota and Butyric-Acid-Mediated Anti-Inflammatory Signaling. Nutrients. 2022; 14(11). PMC: 9183097. DOI: 10.3390/nu14112208. View

18.

Ulluwishewa D, Anderson R, McNabb W, Moughan P, Wells J, Roy N . Regulation of tight junction permeability by intestinal bacteria and dietary components. J Nutr. 2011; 141(5):769-76. DOI: 10.3945/jn.110.135657. View

19.

Zhang W, Zhu B, Xu J, Liu Y, Qiu E, Li Z . Protects Against Antibiotic-Associated Diarrhea in Rats by Modulating Intestinal Defenses. Front Immunol. 2018; 9:1040. PMC: 5954023. DOI: 10.3389/fimmu.2018.01040. View

20.

Adams J, Cory S . The Bcl-2 protein family: arbiters of cell survival. Science. 1998; 281(5381):1322-6. DOI: 10.1126/science.281.5381.1322. View